Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
01/2007
01/03/2007CN1889957A Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
01/03/2007CN1889945A Use of CHP as an inhibitor of glutathione s-transferases and collagen iv
01/03/2007CN1887884A Quinolyl dione derivative and its application in preparing antibiotic medicine
01/03/2007CN1887875A Pyridazinyl amine derivative and its use in preparing small RNA virus inhibitor
01/03/2007CN1887874A Ornidazole derivative and its prepn and use
01/03/2007CN1887871A 2,6-diamino-3,5-dinitrile-4-aryl pyridine derivative and its synthesis and application
01/03/2007CN1887859A Tiopronin amidate and its prepn
01/03/2007CN1887352A Composition for treating eye's fungal and bacterial infection
01/03/2007CN1887351A Hepatitis B preventing vaccine and its prepn
01/03/2007CN1887350A Recombinant vaccine and its use
01/03/2007CN1887349A Helicobacter pylori vaccine based on urease B subunit active segment and its prepn process
01/03/2007CN1887348A Inactivated chicken shigalla vaccine and its prepn
01/03/2007CN1887346A Recombinant human interferon-alpha-thymulin medicine composition and its applied prepn form
01/03/2007CN1887345A Immunopotentiator for treating hepatitis B
01/03/2007CN1887344A Animal interferon compound and its prepn and application
01/03/2007CN1887343A Application of cell factor in resisting tuberculosis infection
01/03/2007CN1887339A Prepn process and quality control technology of cold treating Yankeling granule
01/03/2007CN1887322A Compound Chinese medicine composition and its prepn and use
01/03/2007CN1887321A Chinese medicine decoction for inhibiting hepatitis B virus
01/03/2007CN1887318A Chinese medicine tablet for inhibiting hepatitis B virus
01/03/2007CN1887316A Chinese medicine composition and its prepn process and application
01/03/2007CN1887308A Medicine for treating tinea manuum and tinea pedis and prepn of medicine cream
01/03/2007CN1887305A Prepn process of influenza treating Julan granule and its quality control technology
01/03/2007CN1887301A Application of spanishneedles herb flavonid in preparing medicine for preventing and treating viral hepatitis
01/03/2007CN1887272A Slow released dry azithromycin suspension and its prepn
01/03/2007CN1887271A Azithromycin liposome composition medicine and its prepn process
01/03/2007CN1887256A AIDS treating kadeli'an amine injection and freeze dried powder for injection and their prepn
01/03/2007CN1887107A Prawn disease resisting additive of compound Chinese herbal medicine
01/03/2007CN1293195C Reverse genetic operation system of New castle disease LaSota vaccine strain and its applciation
01/03/2007CN1293192C Immunoregulation polynucleotide and using method thereof
01/03/2007CN1293081C 28-epirapalogs, preparation method, medicament composition and use
01/03/2007CN1293074C Arylindenopyridines with PDE inhibiting activity
01/03/2007CN1292797C Immune regulator, immune regulator food and immune regulator fodder
01/03/2007CN1292795C Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
01/03/2007CN1292794C Preparation of immuno-stimulation composition for hemolycin in monad
01/03/2007CN1292793C Application of kininogenase of human urine in preparing medication for treating pyemia
01/03/2007CN1292784C Gandanqing capsule
01/03/2007CN1292766C Chinese medicinal preparation for treating viral myocarditis and its making method
01/03/2007CN1292751C Imiquimod or its derivative liposome for local skin and its preparing method and use
01/02/2007US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents
01/02/2007US7157578 4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
01/02/2007US7157552 Mutant trichosanthin
01/02/2007US7157495 Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor
01/02/2007US7157494 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency
01/02/2007US7157489 HIV protease inhibitors
01/02/2007US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection
01/02/2007US7157473 Heterocyclic imines such as 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide, used for prophylaxis of hepatitis C virus (HCV)
01/02/2007US7157468 Pyrazole derivatives
01/02/2007US7157465 Adenine derivatives
01/02/2007US7157457 Compounds useful in the treatment of inflammatory diseases
01/02/2007US7157453 Urea substituted imidazoquinolines
01/02/2007US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine
01/02/2007US7157448 Acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
01/02/2007US7157447 Useful for treating HIV infection and AIDS
01/02/2007US7157442 Antibacterial compound
01/02/2007US7157441 Administering an anti-virally effective amount of 1', 2' or 3'-modified nucleoside for therapy of hepatitis C virus infection
01/02/2007US7157437 Administering polynucleotide comprising an immunostimulatory sequence (ISS) to an individual exposed to herpes simplex virus, wherein the ISS comprises the sequence 5'-C, G-3', wherein the polynucleotide comprises a phosphate backbone modification, wherein the polynucleotide is greater than 6 nucleotides
01/02/2007US7157436 An specific oligonucleotide sequence conataining 2-20 base 3'OH, 5'OH synthetic oligonucleotide which induces a response selected from cell cycle arrest, inhibition of cell proliferation, activation of caspases in cancer cells
01/02/2007US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules
01/02/2007US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases
01/02/2007US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
01/02/2007US7157245 Neisserial vaccine compositions and methods
01/02/2007US7157241 Dipeptidyl peptidase IV (DPPIV); given sequences; homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders
01/02/2007US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor
01/02/2007US7157226 probes, vectors and kits; sequences from the Core/E1 region of HCV type 3; detection of HCV infection
01/02/2007US7157225 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
01/02/2007US7157224 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins
01/02/2007US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
01/02/2007US7157081 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
01/02/2007CA2445677C Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
01/02/2007CA2400226C Method for the improvement of islet signaling in diabetes mellitus and for its prevention
01/02/2007CA2383409C Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
01/02/2007CA2368615C Thiadiazolyl urea or thiourea derivatives for antiviral treatment
01/02/2007CA2365495C Viral treatment
01/02/2007CA2261098C Novel erythromycin derivatives, method for preparing same and use thereof as drugs
01/02/2007CA2235996C New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
01/02/2007CA2225628C Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
01/02/2007CA2162468C Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
12/2006
12/28/2006WO2006138507A1 Use of sanglifehrin in hcv
12/28/2006WO2006138195A1 Macrocyclic heterocyclic aspartyl protease inhibitors
12/28/2006WO2006138192A1 Aspartyl protease inhibitors
12/28/2006WO2006137953A1 Phosphono-pent-2-en-1-yl nucleosides and analogs
12/28/2006WO2006137706A1 6-(4-substituted-anilino)pyrimidine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
12/28/2006WO2006137527A1 Thiazole derivative
12/28/2006WO2006137485A1 Novel nitrogenated heterocyclic compound and salt thereof
12/28/2006WO2006137314A1 Radial brush
12/28/2006WO2006137122A1 Anti-aids drug
12/28/2006WO2006136917A1 Triazolylpiperidine derivatives and use thereof in therapy
12/28/2006WO2006136822A1 Inhibitor compounds
12/28/2006WO2006136460A2 New adjuvant
12/28/2006WO2006136162A2 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
12/28/2006WO2006136084A1 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses
12/28/2006WO2006136081A1 A composition containing coenzyme q10 for treating dermatopathy, and its preparation method
12/28/2006WO2006135978A1 Antiviral compounds and methods
12/28/2006WO2006135973A1 Small molecule glycosaminoglycan mimetics
12/28/2006WO2006135965A1 Composition for treating skin lesions
12/28/2006WO2006117461A3 Alkyl-, alkenyl- et alkynyl carbamate derivatives, the preparation and therapeutic use thereof
12/28/2006WO2006099480A3 Stress proteins and peptides and methods of use thereof
12/28/2006WO2006086865A3 Combi-preparation of nucleoside and non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infections
12/28/2006WO2006072625A3 Anti-kir combination treatments and methods